Carregant...

Effectiveness of the SA 14-14-2 Live-Attenuated Japanese Encephalitis Vaccine in Myanmar

Myanmar is an endemic country for the Japanese encephalitis virus (JEV), and the SA-14-14-2 live-attenuated JEV vaccine was first introduced as a catch-up vaccination campaign in 2017. To determine the effectiveness of vaccination by means of neutralizing antibody titers against JEV, a cross-section...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Vaccines (Basel)
Autors principals: Ngwe Tun, Mya Myat, Kyaw, Aung Kyaw, Nwe, Khine Mya, Inoue, Shingo, Thant, Kyaw Zin, Morita, Kouichi
Format: Artigo
Idioma:Inglês
Publicat: MDPI 2021
Matèries:
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC8227667/
https://ncbi.nlm.nih.gov/pubmed/34072933
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/vaccines9060568
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!